Cell & Gene Therapy: Maximizing Commercialization Potential
How to Navigate the Less Obvious Barriers to Brining Advanced & Highly Targeted Treatments to Market
With so many exciting novel treatments emerging from the labs, particularly in the field of gene therapy, biotechs and pharma companies need to understand the potential unknowns as well as the known considerations if they are to optimize their impact in the real world.
In April 2023, in a second live Science Huddle debate, big names from the forefront of gene therapy, as well as regulatory and commercialization experts, came together to advise on some of the less obvious barriers to commercialization, and the most effective strategies to ensure a smooth and viable path to market.
Get your free copy
